S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NYSE:ATIP

ATI Physical Therapy Stock Forecast, Price & News

$3.65
+0.08 (+2.24 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.56
$3.90
50-Day Range
$3.39
$4.55
52-Week Range
$2.81
$13.05
Volume2.41 million shs
Average Volume1.32 million shs
Market Capitalization$756.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ATIP News and Ratings via Email

Sign-up to receive the latest news and ratings for ATI Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.


About ATI Physical Therapy

ATI Physical Therapy, Inc. provides outpatient physical therapy services in the United States. It offers physical therapy, workers' comp rehab, sports medicine, hand therapy, women's health, specialty therapies, home health, complimentary injury screenings, and fitness centers through its 900 locations. The company also offers online physical therapy via its CONNECT platform. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Nursing & personal care facilities
Sub-Industry
N/A
Sector
Medical
Employees
4
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.12 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$756.58 million
Next Earnings Date
11/15/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.72 out of 5 stars

Medical Sector

875th out of 1,361 stocks

Nursing & Personal Care Facilities Industry

5th out of 6 stocks

Analyst Opinion: 3.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












ATI Physical Therapy (NYSE:ATIP) Frequently Asked Questions

Is ATI Physical Therapy a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ATI Physical Therapy in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ATI Physical Therapy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATIP, but not buy additional shares or sell existing shares.
View analyst ratings for ATI Physical Therapy
or view top-rated stocks.

What stocks does MarketBeat like better than ATI Physical Therapy?

Wall Street analysts have given ATI Physical Therapy a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ATI Physical Therapy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is ATI Physical Therapy's next earnings date?

ATI Physical Therapy is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for ATI Physical Therapy
.

What guidance has ATI Physical Therapy issued on next quarter's earnings?

ATI Physical Therapy updated its FY 2021 earnings guidance on Tuesday, October, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $620 million-$630 million, compared to the consensus revenue estimate of $652.72 million.

What price target have analysts set for ATIP?

4 analysts have issued 12-month price targets for ATI Physical Therapy's stock. Their forecasts range from $3.98 to $5.00. On average, they expect ATI Physical Therapy's share price to reach $4.68 in the next twelve months. This suggests a possible upside of 28.1% from the stock's current price.
View analysts' price targets for ATI Physical Therapy
or view top-rated stocks among Wall Street analysts.

Who are ATI Physical Therapy's key executives?

ATI Physical Therapy's management team includes the following people:
  • Mr. Labeed S. Diab, Chief Exec. Director (Age 51)
  • Mr. Greg F. Steil, Founder
  • Mr. Joseph Jordan, Chief Financial Officer
  • Mr. Augustus Oakes, Chief Information Officer
  • Joanne Fong, Sr. VP, Treasurer & Head of Investor Relations
  • Ms. Diana Marie Chafey, Chief Legal Officer
  • Mr. Clifton M. O'Neal, Director of Corp. Communications
  • Mr. Cedric T. Coco, Chief HR Officer (Age 53)
  • Ms. Sheila Denman, Sr. VP
  • Mr. Nathan Bard, Chief Growth Officer

What is ATI Physical Therapy's stock symbol?

ATI Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATIP."

Who are ATI Physical Therapy's major shareholders?

ATI Physical Therapy's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bernzott Capital Advisors (1.82%).

Which institutional investors are buying ATI Physical Therapy stock?

ATIP stock was acquired by a variety of institutional investors in the last quarter, including Bernzott Capital Advisors.

How do I buy shares of ATI Physical Therapy?

Shares of ATIP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ATI Physical Therapy's stock price today?

One share of ATIP stock can currently be purchased for approximately $3.65.

How much money does ATI Physical Therapy make?

ATI Physical Therapy has a market capitalization of $756.58 million.

How many employees does ATI Physical Therapy have?

ATI Physical Therapy employs 4 workers across the globe.

What is ATI Physical Therapy's official website?

The official website for ATI Physical Therapy is www.atipt.com.

Where are ATI Physical Therapy's headquarters?

ATI Physical Therapy is headquartered at 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105.

How can I contact ATI Physical Therapy?

ATI Physical Therapy's mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105. The company can be reached via phone at 630-296-2223 or via email at [email protected].


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.